PHARMATECH AS

1664 ROLVSØY

Finances

Share Ownership

Return on Equity

−4,91 %

Current Ratio

1,14

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	357 210 000	348 868 000	306 717 000	240 897 000
Net Income	−1 007 000	14 172 000	4 254 000	−6 657 000
Total Assets	100 714 000	93 039 000	88 598 000	68 991 000
Total Equity	20 512 000	21 761 000	16 266 000	16 012 000

Income (NOK)	2022	2021	2020	2019
Revenue	357 210 000	348 868 000	306 717 000	240 897 000
Expenditure	357 202 000	331 446 000	301 470 000	252 807 000
Operating Profit	8 000	17 423 000	5 247 000	−7 494 000
Financial Income	1 770 000	2 237 000	3 373 000	743 000
Financial Costs	3 483 000	1 997 000	3 191 000	2 217 000
Financial Balance	−1 713 000	240 000	182 000	−1 474 000
Earnings Before Tax	−1 704 000	17 664 000	5 429 000	−8 968 000
Tax	−697 000	3 492 000	1 175 000	−2 311 000
Net Income	−1 007 000	14 172 000	4 254 000	−6 657 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	9 381 000	8 342 000	6 683 000	4 667 000
Total Current Assets	91 333 000	84 696 000	81 915 000	64 323 000
Total Assets	100 714 000	93 039 000	88 598 000	68 991 000
Total Retained Equity	6 895 000	10 330 000	4 834 000	4 580 000
Total Equity	20 512 000	21 761 000	16 266 000	16 012 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	80 202 000	71 277 000	72 332 000	52 979 000
Total Equity and Debt	100 714 000	93 039 000	88 598 000	68 991 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	352 481 000	348 305 000	306 403 000	240 494 000
Other Income	4 729 000	564 000	314 000	403 000
Revenue	357 210 000	348 868 000	306 717 000	240 897 000
Cost of Goods Sold	243 478 000	220 362 000	209 365 000	169 617 000
Salary Costs	74 233 000	71 893 000	64 865 000	54 600 000
Depreciation	2 487 000	1 791 000	1 361 000	1 681 000
Impairment	0	0	0	0
Expenditure	357 202 000	331 446 000	301 470 000	252 807 000
Operating Profit	8 000	17 423 000	5 247 000	−7 494 000
Financial Income	1 770 000	2 237 000	3 373 000	743 000
Financial Costs	3 483 000	1 997 000	3 191 000	2 217 000
Financial Balance	−1 713 000	240 000	182 000	−1 474 000
Dividends	0	8 000 000	4 000 000	0
Net Income	−1 007 000	14 172 000	4 254 000	−6 657 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	1 155 000	1 074 000	1 050 000	1 399 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	7 972 000	7 014 000	5 378 000	3 013 000
Total Tangible Assets	7 972 000	7 014 000	5 378 000	3 013 000
Total Fiancial Fixed Assets	255 000	255 000	255 000	255 000
Total Fixed Assets	9 381 000	8 342 000	6 683 000	4 667 000
Stock	35 195 000	28 837 000	22 437 000	20 121 000
Total Investments	0	0	0	0
Cash, Bank	2 871 000	4 634 000	18 276 000	3 773 000
Total Current Assets	91 333 000	84 696 000	81 915 000	64 323 000
Total Assets	100 714 000	93 039 000	88 598 000	68 991 000
Total Equity	20 512 000	21 761 000	16 266 000	16 012 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	34 188 000	29 306 000	23 113 000	26 618 000
Unpaid Taxes	4 975 000	4 594 000	4 355 000	5 007 000
Dividends	0	8 000 000	4 000 000	0
Other Current Debt	36 039 000	27 875 000	40 038 000	21 354 000
Total Current Debt	80 202 000	71 277 000	72 332 000	52 979 000
Total Equity and Debt	100 714 000	93 039 000	88 598 000	68 991 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−4,91 %	65,13 %	26,15 %	−41,58 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	0 %	4,99 %	1,71 %	−3,11 %
Current Ratio	1,14	1,19	1,13	1,21
Quick Ratio	2,03	2	1,64	1,96
Equity Ratio	0,2	0,23	0,18	0,23
Gross Profit Margin	31,84 %	36,84 %	31,74 %	29,59 %